http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1206564-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_236c7959e75b60fb5eda21c10945694c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B45-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B30-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6869
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B30-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B45-00
filingDate 2000-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c5f1bbaf8a8815e74c5bcc061729bc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3bfe88014ad2f95e75d40440e3fb4dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4b21be1dc2655c59233a334d70c18e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc96f81405abb778b2400f7e96f0fd5e
publicationDate 2002-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1206564-A1
titleOfInvention Method of designing drugs through reverse polymorphism of target genes
abstract This invention relates to a method of determining the most efficacious and safe drug for a population of subjects to modulate a gene or gene product (e.g., protein or polypeptide) by determining the nucleic acid sequence of all or a portion of a gene and/or all or a portion of the encoded amino acid sequence of that gene with the lowest frequency of polymorphisms.
priorityDate 1999-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3036261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128531769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128479187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420

Total number of triples: 39.